Pharmacotherapy for adolescent alcohol use disorder

Area of Science:

• Psychiatry
• Adolescent Medicine
• Pharmacology

Background:

• Alcohol use disorder (AUD) prevalence increases significantly in adolescents, nearing adult levels by late teens.
• The upcoming DSM-V will consolidate substance abuse and dependence into a single AUD category.
• Adolescents with AUD often present with co-occurring mental health disorders and polysubstance use.

Purpose of the Study:

• To review pharmacotherapeutic options for adolescent alcohol use disorder.
• To discuss medications targeting withdrawal, craving, and comorbid conditions in adolescents with AUD.
• To highlight the need for cautious application and further research on pharmacotherapy for adolescent AUD.

Main Methods:

• Literature review of pharmacotherapy for adolescent alcohol use disorder.
• Analysis of medications targeting specific AUD symptoms and related issues.
• Discussion of clinical considerations, including contraindications and interactions.

Main Results:

• Benzodiazepines may be used for severe alcohol withdrawal under strict supervision.
• Disulfiram can increase abstinence rates in motivated adolescents.
• Naltrexone and acamprosate show potential in reducing alcohol craving and aiding abstinence.
• Pharmacotherapy for comorbid conditions like ADHD and depression is also relevant.
• Potential for drug-alcohol interactions necessitates careful monitoring and patient education.

Conclusions:

• Pharmacotherapy offers several options for managing adolescent AUD, addressing withdrawal, craving, and comorbid disorders.
• Medications like disulfiram, naltrexone, and acamprosate may support abstinence.
• Careful patient selection, monitoring, and integration with psychosocial interventions are crucial.
• Further empirical research is needed to establish the efficacy and safety of these treatments in adolescents.